N-(Cyanomethyl)-3-methoxybenzamide

Catalog No.: 
ACXOWH773
CAS No.: 
40699-31-8
Molecular Formula: 
C10H10N2O2
Molecular Weight: 
190.20
N-(Cyanomethyl)-3-methoxybenzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$137.00InquiryInquiry
250mg95%$249.00InquiryInquiry
1g95%$976.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(Cyanomethyl)-3-methoxybenzamide
IUPAC NameN-(cyanomethyl)-3-methoxybenzamide
Molecular FormulaC10H10N2O2
Molecular Weight190.20
SMILESO=C(NCC#N)C1=CC=CC(OC)=C1
InChI KeyKCFHYHKBRSCYIM-UHFFFAOYSA-N
SynonymN-(Cyanomethyl)-3-methoxybenzamide;Benzamide, N-(cyanomethyl)-3-methoxy-
CAS No.40699-31-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACXOWH773 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTSLY974 route compound structure diagram
    ACTSLY974540-61-4In Stock
  4. Then
  5. ACXOWH773 route product structure diagram
    ACXOWH77340699-31-8
Inquiry

2. ACXOWH773 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGKIH458 route compound structure diagram
    ACGKIH458586-38-9In Stock
  2. Plus
  3. ACTSLY974 route compound structure diagram
    ACTSLY974540-61-4In Stock
  4. Then
  5. ACXOWH773 route product structure diagram
    ACXOWH77340699-31-8
Inquiry

3. ACXOWH773 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZWAM483 route compound structure diagram
    ACZWAM4835368-81-0In Stock
  2. Plus
  3. ACTSLY974 route compound structure diagram
    ACTSLY974540-61-4In Stock
  4. Then
  5. ACXOWH773 route product structure diagram
    ACXOWH77340699-31-8
Inquiry

Comments (0)